Bionano Genomics BNGO
NASDAQ BNGO
$1.48 -0.09 (-5.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bionano Genomics (BNGO) Asset Writedowns and Impairment (2017 - 2024)

Updated

Bionano Genomics (BNGO) posted Asset Writedowns and Impairment of $7.23 million for FY2024, down 90.6% from $77.3 million in FY2023.

Analysis

Bionano Genomics (BNGO) Asset Writedowns and Impairment (2017 - 2024) Analysis & Trends

Since FY2017, Bionano Genomics has reported Asset Writedowns and Impairment for 5 years.

  • Annual Asset Writedowns and Impairment shows a four-year compound annual growth rate of 175.2% (FY2020 to FY2024).
  • The FY2024 figure stands as the lowest annual Asset Writedowns and Impairment since FY2020.
  • Business Quant data shows BNGO's Asset Writedowns and Impairment at $77.3 million in FY2023 and $126,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bionano Genomics 17.43 Mn -47.81 Mn 4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 7.20 Mn
Mar 31, 2024 448,000.00
Sep 30, 2023 77.30 Mn
Dec 31, 2017 240,074.00
API Access

Bionano Genomics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BNGO&period=max&api_key=YOUR_API_KEY